Amzeeq™ (minocycline) – New drug approval
October 18, 2019 - Foamix Pharmaceuticals announced the FDA approval of Amzeeq (minocycline) topical foam, for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older.
Download PDF
